8-K - ALX Oncology Holdings Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. Clinical Update On January 30, 2026, ALX Oncology Holdings Inc. (the “Company”) issued a press release announcing new data from a Phase 1b/2 clini

Other Event

$48.3M

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated January 30, 2026. 104 Cover Page Interactive Data File (embedd

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1